Variant report
Variant | esv3414318 |
---|---|
Chromosome Location | chr4:92884429-92886377 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547902113 | chr4:92884438-92884439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75068958 | chr4:92884446-92884447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541868518 | chr4:92884451-92884452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377707390 | chr4:92884476-92884477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146792185 | chr4:92884507-92884508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs5860259 | chr4:92884557-92884558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561493185 | chr4:92884564-92884565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35986014 | chr4:92884568-92884569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs5860260 | chr4:92884578-92884579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200200504 | chr4:92884579-92884580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530640693 | chr4:92884588-92884589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182290491 | chr4:92884630-92884631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570516934 | chr4:92884644-92884645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116004797 | chr4:92884721-92884722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552275669 | chr4:92884777-92884778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187614839 | chr4:92884787-92884788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535713819 | chr4:92884788-92884789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192536599 | chr4:92884812-92884813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79475387 | chr4:92884813-92884814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538233175 | chr4:92884823-92884824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570968980 | chr4:92884859-92884860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs578134106 | chr4:92884908-92884909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370827527 | chr4:92884948-92884949 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546052268 | chr4:92884984-92884985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184183020 | chr4:92885014-92885015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114600322 | chr4:92885063-92885064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371419329 | chr4:92885094-92885095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201481165 | chr4:92885118-92885119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35034849 | chr4:92885125-92885126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561728551 | chr4:92885133-92885134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543124383 | chr4:92885151-92885152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35107867 | chr4:92885152-92885153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374354636 | chr4:92885160-92885161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs13101686 | chr4:92885172-92885173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13126009 | chr4:92885173-92885174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527649164 | chr4:92885181-92885182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375880303 | chr4:92885188-92885189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs199743950 | chr4:92885191-92885192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs11943150 | chr4:92885197-92885198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373587233 | chr4:92885198-92885199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372623117 | chr4:92885199-92885200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs367843327 | chr4:92885202-92885203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376160327 | chr4:92885212-92885213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13126155 | chr4:92885213-92885214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12509493 | chr4:92885236-92885237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12505831 | chr4:92885237-92885238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368190384 | chr4:92885238-92885239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11943157 | chr4:92885245-92885246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12509494 | chr4:92885246-92885247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12505833 | chr4:92885247-92885248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92879600-92884800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:92880200-92884600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr4:92883600-92884600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr4:92884200-92884600 | Enhancers | Fetal Brain Male | brain |
5 | chr4:92884200-92884600 | Enhancers | NH-A | brain |
6 | chr4:92884200-92884800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr4:92884200-92885000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr4:92884600-92885000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr4:92884600-92885000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr4:92884800-92886400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |